Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Vladan Vučinić"'
Autor:
Maximilian Merz, Danai Dima, Hamza Hashmi, Nausheen Ahmed, Friedrich Stölzel, Tobias A. W. Holderried, Roland Fenk, Fabian Müller, Natalia Tovar, Aina Oliver-Cáldes, Kristin Rathje, James A. Davis, David Fandrei, Vladan Vucinic, Soraya Kharboutli, Ben-Niklas Baermann, Francis Ayuk, Uwe Platzbecker, Anca-Maria Albici, Nathalie Schub, Friederike Schmitz, Leyla Shune, Jack Khouri, Faiz Anwer, Shahzad Raza, Joseph McGuirk, Zahra Mahmoudjafari, Kimberly Green, Cyrus Khandanpour, Marcel Teichert, Barbara Jeker, Michele Hoffmann, Nicolaus Kröger, Bastian von Tresckow, Carlos Fernández de Larrea, Thomas Pabst, Al-Ola Abdallah, Nico Gagelmann
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Despite the astonishing outcomes after chimeric antigen receptor (CAR) T-cell therapy for relapsed refractory multiple myeloma (RRMM), most patients eventually relapse. There are only limited data available on salvage therapies following rel
Externí odkaz:
https://doaj.org/article/494534289884443fbc7448906d6d0a82
Autor:
Harish Sudarsanam, Maximilian Radtke, Raymund Buhmann, Vladan Vučinić, Rami Abou-Jamra, Reinhard Henschler
Publikováno v:
HemaSphere, Vol 7, p e173592c (2023)
Externí odkaz:
https://doaj.org/article/a9e7541e13414fbea3da6e7fe54a06bb
Autor:
Kristin Gerhardt, Madlen Jentzsch, Thomas Georgi, Aleksandra Sretenović, Michael Cross, Enrica Bach, Astrid Monecke, Sabine Leiblein, Sandra Hoffmann, Milena Todorović, Jelena Bila, Osama Sabri, Sebastian Schwind, Georg-Nikolaus Franke, Uwe Platzbecker, Vladan Vučinić
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Up to 60% of patients with aggressive B-cell lymphoma who receive chimeric antigen receptor (CAR) T-cell therapy experience treatment failure and subsequently have a poor prognosis. Allogeneic hematopoietic stem cell transplantation (alloHSCT) remain
Externí odkaz:
https://doaj.org/article/5c98316fe3e34444ac53d08db205dd7e
Autor:
Thomas Walter Georgi, Lars Kurch, Georg-Nikolaus Franke, Madlen Jentzsch, Sebastian Schwind, Carmen Perez-Fernandez, Naima Petermann, Maximilian Merz, Klaus Metzeler, Gudrun Borte, Sandra Hoffmann, Marco Herling, Timm Denecke, Regine Kluge, Osama Sabri, Uwe Platzbecker, Vladan Vučinić
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Purpose Chimeric antigen receptor (CAR)-T cells are a viable treatment option for patients with relapsed or refractory (r/r) aggressive B-cell lymphomas. The prognosis of patients who relapse after CAR-T cell treatment is dismal and factors predictin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ff46f53f4e7d13c5cc1f60cefe09d42
https://doi.org/10.1007/s00432-023-04587-4
https://doi.org/10.1007/s00432-023-04587-4
Autor:
Dietger Niederwieser, Dirk Hasenclever, Wolfgang Berdel, Bart J. Biemond, Haifa Al-Ali, Yves Chalandon, Michel van Gelder, Christian Junghanß, Gösta Gahrton, Mathias Hänel, Rüdiger Hehlmann, Thomas Heinicke, Andreas Hochhaus, Simona Iacobelli, Rien van Marwijk Kooy, Nicolaus Kröger, Jeroen Janssen, Madlen Jentzsch, Frank Breywisch, Mohamad Mohty, Stavroula Masouridi-Levrat, Gert Ossenkoppele, Jacob Passweg, Wolfram Pönisch, Johannes Schetelig, Christoph Schliemann, Sebastian Schwind, Matthias Stelljes, Leo F. Verdonck, Vladan Vucinic, Bob Löwenberg, Jan Cornelissen
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Given the selection of elderly patients with AML in first complete remission (CR1) the advantage of consolidation with allogeneic hematopoietic cell transplantation (HCT) over chemotherapy is still unclear. Newly diagnosed AML patients in CR1 aged
Externí odkaz:
https://doaj.org/article/e24e854d3915489f8bfdf3f02374efc6
Autor:
Anja Grahnert, Sabine Seiffert, Kerstin Wenk, Dominik Schmiedel, Andreas Boldt, Vladan Vucinic, Maximilian Merz, Uwe Platzbecker, Christian Klemann, Ulrike Koehl, Maik Friedrich
Publikováno v:
Biomedicines, Vol 12, Iss 8, p 1641 (2024)
For the monitoring of chimeric antigen receptor (CAR) T-cell therapies, antigen-based CAR detection methods are usually applied. However, for each target-antigen, a separate detection system is required. Furthermore, when monitored CAR T-cells in the
Externí odkaz:
https://doaj.org/article/59aac0cc85b040fb8e4a0a875b373a9c
Autor:
Sebastian Schwind, Lara Bischof, Marius Bill, Juliane Grimm, Jule Ussmann, Donata Backhaus, Dominic Brauer, Tung Pham Thanh, Maximilian Merz, Georg‐Nikolaus Franke, Klaus H. Metzeler, Vladan Vucinic, Marco Herling, Uwe Platzbecker, Madlen Jentzsch
Publikováno v:
HemaSphere, Vol 8, Iss 3, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/4eb2ccce73104646acb42ed71316ebe3
Autor:
Franziska Springer, Peter Esser, Michael Friedrich, Jochen Ernst, Uwe Platzbecker, Vladan Vucinic, Anja Mehnert-Theuerkauf
Publikováno v:
Frontiers in Psychology, Vol 14 (2023)
BackgroundHematological cancer patients must comply with extensive medical instructions to prevent cancer progression or relapse. Psychological comorbidities and patient characteristics have been shown to affect compliance. However, the impact of pos
Externí odkaz:
https://doaj.org/article/25667e3288284b73a89cca6247a2327a
Autor:
Victoria Panagiota, Johanna Franziska Kerschbaum, Olaf Penack, Catarina M. Stein, Christopher M. Arends, Christian Koenecke, Paulina M. Strzelecka, Arnold Kloos, Laura Wiegand, Alina Lasch, Robert Altwasser, Adriane Halik, Razif Gabdoulline, Julia Thomson, Konstantin Weibl, Georg-Nikolaus Franke, Carolina Berger, Justin Hasenkamp, Francis Ayuk, Il-Kang Na, Gernot Beutel, Ulrich Keller, Lars Bullinger, Gerald Georg Wulf, Nicolaus Kröger, Vladan Vucinic, Michael Heuser, Frederik Damm
Publikováno v:
HemaSphere, Vol 7, Iss 10, p e957 (2023)
Recent evidence revealed important interactions between clonal hematopoiesis (CH) and cellular therapies established for the treatment of hematologic malignancies. The impact of CH on safety, efficacy, and outcome of chimeric antigen receptor (CAR) T
Externí odkaz:
https://doaj.org/article/3ee53a5fe55248a48a4f66fd724ad837
Autor:
Madlen Jentzsch, Lara Bischof, Jule Ussmann, Donata Backhaus, Dominic Brauer, Klaus H. Metzeler, Maximilian Merz, Vladan Vucinic, Georg-Nikolaus Franke, Marco Herling, Uwe Platzbecker, Sebastian Schwind
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 12, Pp 1-10 (2022)
Abstract For most patients with acute myeloid leukemia (AML), an allogeneic hematopoietic stem cell transplantation (HSCT) offers the highest chance of cure. Recently, the European LeukemiaNet (ELN) published updated recommendations on the diagnosis
Externí odkaz:
https://doaj.org/article/48de5f2f686c4beabb2ac283efa9a668